S'abonner

Widespread exposure to Crimean-Congo haemorrhagic fever in Uganda might be driven by transmission from Rhipicephalus ticks: Evidence from cross-sectional and modelling studies - 29/11/22

Doi : 10.1016/j.jinf.2022.09.016 
Swaib A. Lule a, Rory Gibb b, Dennison Kizito c, Gladys Nakanjako c, Joseph Mutyaba c, Stephen Balinandi c, Leah Owen a, Kate E. Jones b, Ibrahim Abubakar a, Julius J. Lutwama c, Nigel Field a,
a Institute for Global Health (IGH), University College London, London, UK 
b Centre for Biodiversity and Environment Research, Department of Genetics, Evolution and Environment, University College London, London, UK 
c Department of Arbovirology, Emerging and Re-Emerging Infectious Diseases (DAERID), Uganda Virus Research Institute (UVRI), Entebbe, Uganda 

Corresponding author.

Highlights

Crimean-Congo haemorrhagic fever (CCHF) is a major public health concern throughout Africa.
We did a cross-sectional study at three urban abattoirs receiving cattle from across Uganda.
CCHF virus seropositivity was high in humans (10.3%) and cattle (69.7%), and viral antigen was present in ticks (mainly Rhipicephalus appendiculatus).
Ecological modelling predicted high human CCHF risk across much of Uganda.
Predicted environmental suitability was low for Hyalomma, but high for Rhipicephalus and Amblyomma ticks.

Le texte complet de cet article est disponible en PDF.

Summary

Background

Crimean-Congo haemorrhagic fever (CCHF) is a widespread tick-borne viral infection, present across Africa and Eurasia, which might pose a cryptic public health problem in Uganda. We aimed to understand the magnitude and distribution of CCHF risk in humans, livestock and ticks across Uganda by synthesising epidemiological (cross-sectional) and ecological (modelling) studies.

Methods

We conducted a cross-sectional study at three urban abattoirs receiving cattle from across Uganda. We sampled humans (n = 478), livestock (n = 419) and ticks (n = 1065) and used commercially-available kits to detect human and livestock CCHF virus (CCHFV) antibodies and antigen in tick pools. We developed boosted regression tree models to evaluate the correlates and geographical distribution of expected tick and wildlife hosts, and of human CCHF exposures, drawing on continent-wide data.

Findings

The cross-sectional study found CCHFV IgG/IgM seroprevalence in humans of 10·3% (7·8–13·3), with antibody detection positively associated with reported history of tick bite (age-adjusted odds ratio = 2·09 (1·09–3·98)). Cattle had a seroprevalence of 69·7% (65·1–73·4). Only one Hyalomma tick (CCHFV-negative) was found. However, CCHFV antigen was detected in Rhipicephalus (5·9% of 304 pools) and Amblyomma (2·9% of 34 pools) species. Modelling predicted high human CCHF risk across much of Uganda, low environmental suitability for Hyalomma, and high suitability for Rhipicephalus and Amblyomma.

Interpretation

Our epidemiological and ecological studies provide complementary evidence that CCHF exposure risk is widespread across Uganda. We challenge the idea that Hyalomma ticks are consistently the principal reservoir and vector for CCHFV, and postulate that Rhipicephalus might be important for CCHFV transmission in Uganda, due to high frequency of infected ticks and predicted environmental suitability.

Funding

UCL Global Challenges Research Fund (GCRF) and Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET) funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) under the EU Horizon 2020 Framework Programme for Research and Innovation.

Le texte complet de cet article est disponible en PDF.

Keywords : Crimean-Congo haemorrhagic fever, Epidemiology, Ecology, Abattoir, Livestock, Ticks, One health, Uganda


Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 85 - N° 6

P. 683-692 - décembre 2022 Retour au numéro
Article précédent Article précédent
  • Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trial
  • G. Myring, A.G. Lim, W. Hollingworth, H. McLeod, L. Beer, P. Vickerman, M. Hickman, A. Radley, J.F. Dillon
| Article suivant Article suivant
  • Risk factors for Crimean-Congo Haemorrhagic Fever (CCHF) virus exposure in farming communities in Uganda
  • Stella A. Atim, Shirin Ashraf, Sandra Belij-Rammerstorfer, Anna R Ademun, Patrick Vudriko, Teddy Nakayiki, Marc Niebel, James Shepherd, Stephen Balinandi, Gladys Nakanjako, Andrew Abaasa, Paul C.D. Johnson, Steven Odongo, Martin Esau, Milton Bahati, Pontiano Kaleebu, Julius J Lutwama, Charles Masembe, Teresa Lambe, Emma C. Thomson, Robert Tweyongyere

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.